feed rss
decorazione
Star Alliance

FREE COMMUNICATION 25

 

ROOM CAMLICA     08:00 - 09:30

 

 

Diabetes - basic research

 

 

Chairs: Jesus Egido, Madrid, Spain
             Bo Feldt-Rasmussen, Copenhagen, Denmark

 

FREE COMMUNICATIONS


TO018
ONCOSTATIN M-MEDIATED EFFECTS ON TNF-a- AND IL-1b-INDUCED EXPRESSION OF CCL5/RANTES, TSP-1 AND TNC IN HUMAN PROXIMAL TUBULAR CELLS.
Rita Sarkozi, Markus Pirklbauer, Gert Mayer, Herbert Schramek. Dept Internal Medicine IV, Nephrology and Hypertension, Innsbruck Medical Univ, Innsbruck, Austria.
 
TO019
HEPATOCYTE GROWTH FACTOR GENE THERAPY ENHANCES M2 MACROPHAGES AND MAY INDUCE KIDNEY REPAIR IN A MOUSE MODEL OF DIABETIC NEPHROPATHY
Maria Flaquer,1 Marcel.La Franquesa,1 August Vidal,2 Nuria Bolaños,1 Joan Torras,1 Nuria Lloberas,1 Josep M Grinyo,1 Josep M Cruzado.1 1Nephrology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain; 2Physiology, HUB, Hospitalet de Llobregat, Barcelona, Spain.
 
TO020
ATP-P2X4 SIGNALING MEDIATES NLRP3 INFLAMMASOME ACTIVATION:A NOVEL PATHWAY OF DIABETIC NEPHROPATHY.
Kehong Chen, Weiwei Zhang, Jianguo Zhang, Jinghua Zhang, Yani He. Dept Nephrology, Daping Hosp, Third Military Medical Univ, Chongqing, China.
 
TO021
PBI-4050, A NOVEL FIRST-IN-CLASS ANTI-FIBROTIC COMPOUND, REDUCES KIDNEY HYPERFILTRATION, PROTEINURIA, HEPATIC STEATOSIS, AND THE EXPRESSION OF INFLAMMATORY/FIBROTIC MARKERS IN KIDNEY AND LIVER IN DIABETIC DB/DB MOUSE MODEL.
Lyne Gagnon, Lilianne Geerts, André Doucet, François Sarra- Bournet, Martin Leduc, Shaun Abbott, Jean-Simon Duceppe, Boulos Zacharie, Christopher Penney, Pierre Laurin, Brigitte Grouix. ProMetic BioSciences Inc., Laval, QC, Canada.
 
TO022
THE CCR2 ANTAGONIST CCX140 IMPROVES RENAL FUNCTION IN TWO TYPES OF DIABETIC MICE EXPRESSING HUMAN CCR2
Jay Powers, Timothy Sullivan, Zhenhua Miao, Rob Berahovich, Linda Ertl, Matthew Walters, Shichang Miao, Juan Jaen, Thomas Schall. ChemoCentryx Inc., Mountain View, CA, USA.


back to the timetable

 

final programme "day by day" - may 18 - 21, 2013

today